Skip to main content
background gradient

Volume 10Issue 10

Industry Update

Free Access
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment
  • Alex Simpson and
  • Sreeram V Ramagopalan
pp797–799
Published Online:6 May 2021
Preview Abstract

Systematic Review

Open Access
Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease
  • Philippe Godeberge,
  • Parvez Sheikh,
  • Varut Lohsiriwat,
  • Abel Jalife, and
  • Yury Shelygin
pp801–813
Published Online:30 April 2021
Preview Abstract

Short Communication

Free Access
DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain
  • Cristobal Morales,
  • Virginia Bellido,
  • Cristina Tejera,
  • Fernando Goñi,
  • Rafael Palomares,
  • Cristina Sevillano,
  • Diego Bellido,
  • Alfonso Soto,
  • Miguel Ángel Mangas,
  • Manuel A Botana, and
  • Irene Caballero
pp815–821
Published Online:6 May 2021
Preview Abstract
Free Access
Validity of comorbidity adjustment scores in estimating in-hospital mortality in individual subgroups of race/ethnicity
  • Virginia E Tangel,
  • Briana Lui,
  • Dima El Halawani Aladdin,
  • Kane O Pryor, and
  • Robert S White
pp823–829
Published Online:28 May 2021
Preview Abstract

Research Article

Open Access
Economic analysis of the use of video laryngoscopy versus direct laryngoscopy in the surgical setting
  • Jianying Zhang,
  • Wei Jiang, and
  • Felipe Urdaneta
pp831–844
Published Online:27 April 2021
Preview Abstract
Open Access
Robot-assisted minimally invasive transforaminal lumbar interbody fusion versus open transforaminal lumbar interbody fusion: a retrospective matched-control analysis for clinical and quality-of-life outcomes
  • Xiuyuan Chen,
  • Qingxin Song,
  • Kun Wang,
  • Zhi Chen,
  • Yingchao Han,
  • Hongxing Shen, and
  • Quan Li
pp845–856
Published Online:28 April 2021
Preview Abstract
Free Access
Clinical and utilization outcomes associated with tumor mutational burden in a real-world pan-tumor population
  • Santosh Gautam,
  • Sumesh Kachroo,
  • Richard W DeClue,
  • Maxine D Fisher, and
  • Anirban Basu
pp857–868
Published Online:28 May 2021
Preview Abstract
Free Access
Access to medicines in the Brazilian Unified Health System’s primary health care: assessment of a public policy
  • Mariana M Barbosa,
  • Thais A Moreira,
  • Renata CRM Nascimento,
  • Mariana MG Nascimento,
  • Francisco A Acurcio,
  • Brian Godman,
  • Augusto A Guerra, and
  • Juliana Alvares-Teodoro
pp869–879
Published Online:25 May 2021
Preview Abstract